We experienced a case of PPFE who developed fatal acute deterioration of the disease. Postmortem histologic exam suggested possible novel pathophysiology in acute exacerbation of the disease. Methods: Retrospective analysis the clinical data of 45 diabetic patients with IPF, to explore the characters of clinical manifestation, pulmonary function, chest radiology, laboratory examination and pathological examination and to summarize the prognosis.
The second hospital of JiLin University, China Background and Aims: To explore the clinical features, treatment and prognosis of diabetic patients with idiopathic pulmonary fibrosis (IPF).
Methods: Retrospective analysis the clinical data of 45 diabetic patients with IPF, to explore the characters of clinical manifestation, pulmonary function, chest radiology, laboratory examination and pathological examination and to summarize the prognosis.
Results: Patients showed progressive dyspnea and cough, and some (75.6%) had hypoxemia. The lung function of the patients present with the restricted ventilation 75.6%( 34 /45), diffuse function 64.4%( 29 /45) and small airway obstruction 60.0% ( 27 /45). The lung CT of these patients showed lung multiple grid and strip shape. 22 routine bronchoscopic lung biopsy showed more neutrophils infiltrating in pathological examination. 40 patients received oral hypoglycaemic drugs or hypodermic injection of insulin to control blood sugar. Glucocorticoids were used in 36 patients. The 40 patients (88.9%) improved, and 5 patients (11.1%) died of respiratory failure.
Conclusion:
For diabetic patients, lung function and chest radiography should be checked regularly to find IPF early. For diabetic patients with IPF, it is recommended that intravenous use or inhalation of small doses of glucocorticoid to improve prognosis on the basis of controlling blood sugar. Background and Aims: Interstitial pneumonia (IP) is frequently complicated by lung cancer. Despite the regular chest X-ray follow up, lung cancer is often diagnosed at progressive stage in IP patients. We carried out this study to investigate the previous history of chest imaging in advanced lung cancer with IP patients and tried to identify the optimal interval of examination.
Methods: Four hundred and twenty-one patients were diagnosed with advanced lung cancer during 2012 to 2014 in Teikyo University Hospital. Among those patients, 22 patients with IP were eligible for current study (lung cancer stage III: n = 7, IV: n = 15) and we retrospectively investigated the previous chest X-ray histories. Patients without previous imaging history were excluded.
Results: Median duration from last chest-X ray examination to diagnosis of lung cancer was 7 months (3 months in stage III (n = 7), 10 m in stage IV). Although the median duration in NSCLC group was 6.8 m, the duration tended to be shorter in SCLC group (4.8 m). The median duration in non-CPFE group was significantly shorter than CPFE group (2.8 vs 7.7 m). In half of cases, tumor shadow could not be identified in last chest X-ray examination.
Conclusion: This study suggests that chest imaging for IP patients should be performed in at least 4 to 6 months interval to detect lung cancer in early stage. Background and Aims: The IPF and NSCLC have an obvious correlation in gene mutation, epigenetics and the of activation specific signalling pathways. The tyrosine kinase pathway which is the important signalling pathway is strongly activated not only in many cancers but also in IPF. The pathway once activated will regulate many important physiological processes, which are associated with the initiation or progression of cancer. In this study, we focused our research on the expression of FGF2/FGFR2, and the downstream ERK1/2/p-ERK1/2 in NSCLC patients, IPF patients and other non-malignant diseases patients to verify the common pathogenesis between the IPF and NSCLC.
Methods: Quantitative reverse transcription-polymerase chain reaction (RT-q PCR) and western blot were used to detect the expression of FGF2, FGFR2, ERK1/2 and p-ERK1/2 in carcinoma tissue and paracarcinoma tissue in NSCLC patients, bronchoalveolar lavage fluid in the IPF patients and the normal control group. The normal control group refers to the patients with the main symptom of cough and confirmed healthy by the bronchoalveolar lavage.
Results: Compared with the para-carcinoma tissue, the ERK1/2 mRNA expression is significantly increased (P < 0.001) in lung carcinoma tissue. Compared with the para-carcinoma tissue, the p-ERK1/2 protein expression in lung carcinoma tissue is significantly increased (P < 0.001).
Compared with the para-carcinoma tissue, the FGF2 mRNA and protein expression in lung carcinoma tissue are significantly increased P < 0.001).Compared with the control group, the FGF2 protein expression in IPF patients'bronchoalveolar lavage fluid is increased (P = 0.010).
Compared with the para-carcinoma tissue, the FGFR2b mRNA is significantly decreased (P < 0.001) and the FGFR2c mRNA and protein 
